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Abstract 
In C. albicans the deletion of GUP1 causes drastic alterations at both morphologic and 
physiologic levels, compromising several virulence factors, such as (i) peculiar colony 
morphology, (ii) filamentous growth defects, (iii) impairment on the ability of cells to 
adhere, invade and form biofilms, and (iv) resistance to the antifungal agents. 
Gup1 is a yeast O-acyltransferase with close homologues in higher Eukaryotes, which 
has been implicated in the regulation of the Hedgehog pathway in mouse. Based on that, 
a primarily aim for the present work concerned the creation of a strain collection of C. 
albicans ∆gup1 mutant harboring available GUP1 homologues from well known model 
organisms/higher Eukaryotes: yeast Saccharomyces cerevisiae (ScGUP1), Fly 
Drosophila melanogaster (DmGUP1), Mouse Mus musculus (MmGUP1), and Man 
Homo sapiens (HsGUP1). These transformed C. albicans strains were tested for several 
virulence factors, such morphology and differentiation, agar adherence and invasion 
capacities, and resistance to antifungals agents. Another important purpose of this study 
was to obtain for the first time a detailed characterization of the proteins secreted onto 
the C. albicans extracellular matrix. For that we imitated biofilm formation on plate and 
compare the wt, ∆gup1 mutant and transformants.   
Our results suggest an apparent initial development of hyphae/pseudohyphae cells in 
liquid cultures, when the GUP1 homologues are inserted into ∆gup1 mutant strain, yet 
the same strains are unable to give continuity to that differentiation. In agreement, on 
solid cultures those transformant strains, though displaying a colony morphology closer 
to wt strain were powerless to differentiate into hyphas. Moreover all the 
Ca∆gup1GUP1 homologues showed the same impairment displayed by ∆gup1mutant 
strain, in what regards adherence and agar invasion capacities. Concerning antifungal 
resistance, it seems that only DmGUP1 gene complements ∆gup1 mutation. 
Additionally, the analysis of ∆gup1 mutant extracellular matrix protein profile revealed 
lack of some proteins, presence of other that were not on wt profile and different 
concentration of some of the common proteins, suggesting that the lack of Gup1p 
triggers C. albicans to produce or to excrete distinct proteins. In conclusion, our results 
open a field of options to future research, mainly regarding proteomics of ECM and its 
relation to the virulence of C. albicans.  
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Resumo 
A deleção do gene GUP1 em C. albicans provoca-lhe alterações drásticas tanto a nível 
morfológico como fisiológico, comprometendo vários factores de virulência tais como a 
capacidade de desenvolver hifas, a capacidade de aderir invadir e formar biofilmes, 
alterações de morfologia nas colónias bem com um aumento da resistência a 
antifúngicos. 
A proteína Gup1p é uma O-aciltransferase presente em leveduras e que partilha uma 
elevada homologia com os eucariotas superiores, tendo sido descrita como essencial na 
regulação da via Hedgehog, em ratinhos. Com base nestes conhecimentos, foi proposto 
como 1° objectivo deste trabalho a criação de uma colecção de estirpes de C. albicans 
mutada no gene GUP1 complementada com vários homólogos do GUP1 de eucariotas 
superiores: levedura Saccharomyces cerevisiae (ScGUP1), mosca Drosophila 
melanogaster (DmGUP1), ratinho - Mus musculus (MmGUP1), humano -Homo sapiens 
(HsGUP1). Nestas novas estirpes foram testados vários factores de virulência: 
morfologia, capacidade de diferenciação em filamentos, aderência e invasão ao agar, e 
ainda a resistência a antifúngicos. Um outro objectivo importante deste trabalho 
consistiu na caracterização detalhada das proteínas secretadas para a matriz extracelular 
da C. albicans. Para tal simulou-se a formação de biofilmes em placas comparando as 
estirpes wt e mutada no GUP1.  
Os resultados obtidos mostram que os vários homólogos do GUP1 quando inseridos na 
estirpe mutada tiveram a capacidade de iniciar diferenciação em hifas/pseudohifas, em 
meio líquido. No entanto, não foram aptas para dar continuidade à referida 
diferenciação. Do mesmo modo, em meio sólido as colónias destas estirpes foram 
morfologicamente mais semelhantes à wt que ao mutante GUP1, sem no entanto 
apresentarem hifas. Para além disso, nenhum dos transformantes mostrou capacidade de 
aderir ou invadir o agar. Quando testada a sua resistência a antifúngicos apenas a estirpe 
complementada com o DmGUP1 (da mosca) reverteu o fenótipo do mutante GUP1. Por 
fim, a análise das proteínas da matriz extracelular da wt e do mutante GUP1 revelou 
perfis proteicos muito distintos, presença de diferentes proteínas e também em 
diferentes quantidades, o que sugere que a ausência do GUP1 provoca uma alterada 
excreção de proteínas. 
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1. Candida and Candidosis 
Since the beginning of the 80s, fungi, mainly Candida yeast species have emerged as 
important causes of serious human infections (Blumberg et al, 2001). This is 
particularly true among the immuno-compromised patients and those hospitalized with 
serious sickness (Rees et al, 1998). The rise of infections caused by Candida species 
(candidosis) are largely due to a limited number of sources: increasing number of AIDS 
seropositives, transplants, novel cancer treatments, and a widespread use of large-
spectrum antibiotics and indwelling medical devices (Pfaller et al, 2007). In the early 
90s, the introduction of triazoles like fluconazole appeared like a promising option to 
treat systemic fungal infections (Trick et al, 2002). Still, the incidence of mortality rates 
associated with this infectious disease remains the same for more than a decade. This 
has been explained not only by the growing resistance of Candida species to the 
antifungal agents, as to delays in the administration of appropriate antifungal therapy 
(Pfaller et al, 2007). Moreover, despite the fact that Candida albicans is the most 
common species causing candidosis, approximately 66%, other non albicans Candida 
species have emerged as potential human pathogens: C. glabrata (≈12%), C. 
parapsilosis (≈11%), C. tropicalis (≈10%) and C. krusei (≈1%) (Trick et al, 2002). 
C. albicans is a normal commensal of human microflora, residing at the gastrointestinal 
tract, the oral cavity, the vaginal and urinary environment, yet this organism is also an 
opportunistic pathogen (Pfaller et al, 2007). This diploid yeast, thought until recently to 
be asexual (Bennett et al, 2003), causes infections such as denture stomatitis, thrush and 
urinary tract-infections, but can also provoke more severe systemic infections (Pfaller et 
al, 2007). The severity of such infections depends on the immune mechanisms of the 
host that are impaired (Calderone et al, 1997). These can be generally separated in: (i) 
mucosal infections and (ii) blood stream infections. Mucosal infections, medically 
called pseudomembranes candidosis are characterized by white spots and affect vaginal, 
esophageal, oral and gastrointestinal mucosae. Blood stream infections, also known as 
candidemia, affect individuals who have deficient number of neutrophils i.e. immuno-
compromised. Candidemia of the internal organs it’s called disseminated candidosis, 
and it is a serious medical condition that leads to mortality rates between 30% and 50% 
(Sudbery et al, 2011).  
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The pathogenicity of C. albicans is based on several attributes of this species, 
denominated virulence factors, and on the development of specific strategies that assist 
in the yeast ability to colonize host tissues, cause disease, and overcome host defences 
(Naglik et al, 2003). These include (i) the production of certain proteins-secreted 
hydrolytic enzymes, (ii) the dimorphic transition (morphogenetic conversion from 
budding yeast into filamentous yeast), the ability to switch between different cell 
phenotypes commonly named as phenotypic switching, (iii) the production of invasive 
biomolecules such proteases and phospholiases, which enable C. albicans to adhere and 
invade different inert and biological substrates, (iv) the ability to form biofilms, (iv) and 
the immunomodulation of the host defense and the antigenic variability (Martinez et at, 
1998; Calderone et al, 1997). This complexity, agrees with an opportunistic infectious 
agent life cycle, and therefore with C. albicans considerable genome plasticity (Sudbery 
et al, 2011). An example is the appearance of an isochromossome V that carries genes 
involved on the expression of ergosterol pathway enzymes targeted by azole drugs 
(Selmecki et al, 2006).   
 
1.1 Virulence factors/morphogenesis in C. albicans 
C. albicans morphogenic transition is defined as the switch between unicellular yeast 
cells and a filamentous growth form (Calderone et al, 2001). In the yeast form, the cells 
reproduce by budding-off daughter cells that typically disassociate from the mother cell. 
In the filamentous or hyphal mode, the cells continually grow at a tip which leads to an 
elongated tube-like structure – hyphae – made of multiple contiguous cells separated by 
septae (Whiteway et al, 2007). In addition this fungus can naturally occur in other 
morphological forms characteristic of specific cellular functions, namely the opaque 
form - described as characteristic of mating-competent cells (Soll, 2004), and the 
chlamydospore form - characterized by a ticked cell wall typically formed under 
suboptimal growth conditions (Fabry et al, 2003), and the pseudohyphal form consisting 
of the state between yeast and hyphal form, which coexists with the yeast and hyphal 
forms during infections (Sudbery et al, 2004). 
Fungal invasion has been described to depend on these changes in morphology 
especially hyphae growth, which tip extension can generate significant tip pressures for 
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tissue penetration (Gow et al, 2002). Different morphological forms confer distinct 
properties that have advantages at different stages and sites of infection. During the 
earliest stages of infection, C. albicans forms hyphae. Once infection is established 
these are replaced by both yeast cells and pseudohyphae (Gow et al, 2002). 
The first studies on C. albicans filamentous growth ignored the pseudohyphae state, or 
tended to consider it as an intermediate stage between yeast and true hyphal growth 
forms. Sudbery and collaborators work (Sudbery et al, 2004) described a systematic 
evaluation of these morphological states, having into account the next parameters; 
 
- Cell shape: hyphae have no constrictions at the neck of mother cell and have 
parallel side in all entire length; pseudo-hyphae have constrictions at neck of 
mother cell and the length and width vary enormously. 
 
- Cell cycle: is fundamental for the mode of growth and organization, and is 
related to the location of the first mitoses within the germ tube (hyphae) or 
across the bud neck (pseudo-hyphae).  
 
It has been established also that the environmental conditions that favor hyphae, yeast 
or pseudohyphae growth are different (Odds, 1988). Hyphal growth is promoted at 
conditions such as: growth at 37°C, presence of serum, neutral pH, high CO2 
concentrations (Sudbery et al, 2011) and presence of N-acetylglucosamine (Cassone et 
al, 1985). On the other hand, yeast growth is favored by a growth at lower temperatures 
30°C (or under) and acidic pH (4.0).  
Hyphal development in C. albicans is regulated by at least five different pathways: i) 
the conserved pH signaling pathway, that activates hyphal growth in response to 
environment pH, (ii) the morphogenetic pathway induced by the transcription factor 
Cph2p, (iii) the hyphal formation pathway, stimulated by Czf1p, (iv) the basic helix-
loop-helix Efg1p transcription factor, involved in the Ras-cAMP signaling pathway that 
responds to nutrient deprivation and, (v) the mitogen activated protein (MAP) kinase 
pathway that activates hyphal development in response to nutrient limitation (reviewed 
by Gow et al, 2002). 
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Hyphae and pseudo-hyphae formation is the ultimate phenotype of polarized growth. In 
the yeast form, polarized growth is defined by a crescent-shaped polarisome at the tip of 
the growing bud (Fig. 1) (Whiteway et al, 2007). The processes of polarized growth in 
C. albicans yeast form and pseudo-hyhae formation in S. cerevisiae are similar. It 
occurs through formation of secretory vesicles that are transported to a specific site of 
polarized growth, which is marked by cortical markers (Sudbery et al, 2011). These 
activate Cdc42, a protein involved in the regulation of the cell cycle, resulting in the 
formation of the polarisome, the exocyst and a septing ring. The septin ring organizes 
the arrangement of the primary and the secondary septae between the mother and 
daughter cells. The polarisome initiates the formation of actin filaments along which 
post-Golgi secretory vesicles are delivered to the sites of polarized growth, and where 
they dock with the exocyst before fusing with the plasma membrane (Fig. 1) (Sudbery 
et al, 2011). In hyphae forms, the polarized growth is considerably different. There is a 
structure rich in secretory vesicles formed at the apex, called Spitzenkörper or the tip 
body (Sudbery et al, 2011).  
 
Fig. 1. Cell cycle of yeast and the first cell cycle of hyphae and pseudohyphae. Extract from Sudbery et 
al, 2004. 
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1.2 C. albicans biofilms 
The ability to form biofilms it is intimately associated with the ability to cause infection 
and is considered an important virulence determinant during candidosis. Candidosis are 
frequently seeded from biofilms developed on medical devices (Nobile et al, 2009). The 
most common Candida associated with biofilm formation is C. albicans (Ramage et al, 
2005). C. albicans can colonize and develop a biofilm on almost any medical device 
(Uppuluri et al, 2009), including prostheses, implants, several types of catheters, etc. 
Furthermore, the formation of biofilms in medical devices besides serving as a source 
for infections, can also cause the failure of the device (Nett et al, 2006). 
 
1.2.1 Formation and features of C. albicans biofilms 
 
Biofilm formation is a process in which microorganisms irreversibly attach and grow on 
a surface producing and secreting polymers that facilitate the attachment and a matrix 
formation. This corresponds to a change in the microorganism growth rate and gene 
transcription profile (Donlan, 2001). 
 
The progression to a mature biofilm depends of three factors: cell adhesion, 
extracellular matrix production and transition yeast-to-hyphae (Nett et al, 2006). In 
biofilm formation cell initially adhere to biomaterial surfaces (Li et al, 2003). The 
characteristics of the substratum could affect the rate and extend of the attachment. In 
general, biofilms develop more quickly in rougher and more hydrophobic materials 
(Donlan, 2001). The attachment of Candida to biomaterials is mediated by nonspecific 
factors like hydrophobicity and electrostatic forces, and by specific adhesins that 
recognize ligands in the conditioning films, like serum or salivary proteins (Ramage et 
al, 2005). A mature biofilm of Candida species is composed by a complex three-
dimensional structure and displays extensive spatial heterogeneity (Ramage et al, 2005). 
The biofilm acts like a “filter” to entrap, among others, nutrients and water and facilitate 
their influx as well as the disposal of waste products throughout the many layers of cells 
(Ramage et al, 2005). Observations through Scanning Electron Microscopy (SEM) 
reveal the fully mature C. albicans biofilms as a dense network of yeasts, hyphae, 
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pseudohyphae, as well as extracellular polymeric material, the matrix (Ramage et al, 
2005; Hawser et al, 1994).  
 
 
 
 
 
 
 
Fig. 2. SEM image of mature C. albicans biofilm. Bar corresponds to 10 µm. Extracted from Ramage et 
al, 2005. 
 
1.2.2 Morphogenic conversion in C. albicans biofilm 
It is widely recognized that morphogenesis plays a pivotal role in the development of C. 
albicans biofilms (Ramage et al, 2005). Baillie and collaborators demonstrated that 
hyphae are essential elements of the architecture and structural integrity of mature 
biofilm (Baillie et al, 1999). In this study they compare the biofilms produced by two 
wild-type (wt) strains with those formed by two mutants, incapable of yeast and hyphal 
growth, respectively. An analysis using SEM revealed that the biofilms of the wt strains 
consists in two different layers: a basal yeast layer and a thicker hyphal layer. On the 
other hand, the hyphae-mutant produced only the basal layer and the yeast mutant 
formed only a thicker layer. The biofilms of the yeast mutants were more easily 
detached that the ones formed by wt strains, which suggested that the basal yeast layer 
is crucial for the anchoring of the biofilm to the surface (Baillie et al, 1999). More 
recently our group found that Cagup1Δ null mutant strain was not able to form typical 
biofilm structures, presenting much less hyphae/pseudo-hyphae comparing to wt 
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(Ferreira et al, 2010). Still, dimorphism may not be an absolute prerequisite for biofilm 
formation, since biofilms harboring only yeast cells have been described (Ramage et al, 
2010). 
Very little is still known about the regulation of biofilm formation, yet, some genetic 
studies have been made. The regulator Efg1 protein was described as a key factor in the 
formation and subsequent development of mature C. albicans biofilms in a variety of 
biological and artificial surfaces (Ramage et al, 2002) and Zap1p, a zinc-responsive 
regulatory protein as a negative regulator of biofilm maturation (Nobile et al, 2009). 
C. albicans quorum sensing modulates all stages of biofilm life cycles: attachment, 
maturation and dispersal (Donlan, 2002; Deveau et al, 2011). Farnesol, a C. albicans 
autoregulatory molecule that regulates the transition between yeast and hyphae form, is 
the best characterized quorum sensing molecule, and leads to a reduction on the biofilm 
sizes (Hornby et al, 2001; Deveau et al, 2011). 
 
1.2.3 Biofilms resistance to antifungals 
The increased resistance of biofilm-associated infections to antimicrobial agents is a 
serious problem for public health (Donlan, 2001). Presently, there are four groups of 
drugs available to treat fungal infections: (i) the antifungal agents that inhibit 
macromolecule synthesis (e.g. flucytosine), (ii) the ones that impair membrane barrier 
function (nystatin and amphotericin), (iii) the inhibitors of ergosterol synthesis (azoles 
derivates such as clotrimazole, ketoconazole or fluconazole) and, (iv) drugs that interact 
with microtubules (e.g. Griseofulvin) (Bossche, 1997). 
Hitherto, it looks like that no class of antifungal agent is immune to the development of 
resistance. Therefore it becomes necessary to consider the development of a systematic 
program of in vitro susceptibility testing, in order to take therapeutic decisions (Pfaller 
et al, 2007). Several works showed Candida biofilms high levels of resistance to 
antifungal agents and proposed explanations. It has been suggested, for instance that the 
matrix of extracellular polymeric material would exclude or limit the access of the drug 
(Al-Fattani et al, 2006). Still, in another study, Al-Fattani and collaborators (Al-Fattani 
et al, 2006) found that the matrix did not constitute a barrier for 5 clinically used 
antifungals of different chemical structure, suggesting that the matrix plays a minor role 
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in drug resistance. In their study, they compared biofilms incubated without agitation 
(that have little matrix) with biofilms incubated with gentle shaking (produce more 
matrix material) and these did not show significant differences in susceptibility to any 
of the drugs tested (Al-Fattani et al, 2006). Other mechanism pointed to have a role on 
Candida biofilms resistance was the nutrient limitation and growth impairment, since 
mature biofilms are more resistant to antifungals (Ramage et al, 2005).  
 
1.3 Extracellular matrix (ECM) 
One of the most important features of biofilms is the extracellular matrix. ECM is a 
three-dimensional highly hydrated gel-like environment where the microorganims are 
mainly immobilized (Flemming et al, 2000). 
The composition of the matrix varies according to the nature of the organisms present. 
For instances, exopolysaccharides are the most abundant matrix polymers of bacterial 
biofilms. These can be attached to carboxyl, sulphate or phosphate groups becoming 
negatively charged. Nucleic acids, lipids, uronic acid and proteins can also be present 
but in smaller amounts (Al-Fattani et al, 2006). The ECM of mammalian cells is mainly 
constituted by a large variety of fibrous proteins (such as glycoproteins and 
proteoglycans) and glycosaminoglycans, although it varies from tissue to tissue 
(Mecham, 2011). In terms of functions, mammalian ECM is much more sophisticated 
and diverse than the ECM of yeasts, being for instance essential on the repair of the 
tissue (Mecham, 2011). In C. albicans ECM were identified structures called “towers”, 
which are microcolonies of the matrix, separated by water channels that allow an 
efficient nutrient circulation within the biofilm (Donlan et al, 2002). 
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Fig. 3. C. albicans forms dense biofilms composed of yeast cells, hyphae, and extracellular matrix. 
Images produced using SEM. (ref:http://hsc.unm.edu/som/medicine/id/msclinic.shtml). 
More recently, it was proposed that extracellular DNA is also a component of C. 
albicans ECM and that it may play a crucial role in biofilms structural role, based on the 
observation that the addition of exogenous DNA increases the biofilm mass and 
conversely, when treated with DNase the biofilm mass decreases (Martins et al, 2010). 
Some extracellular polysaccharides and proteins have been reported to be essential 
components of the matrix (Sutherland, 2001). Also dead cells have been observed in 
some biofilms, which suggests that cell debris can accumulate in the ECM (Webb et al, 
2003). Possibly the extracellular DNA derives from these dead cells. Furthermore, it 
was recently described that the matrix has a function of cellular protection from 
surrounding environment, not only by preventing the uptake of drugs, by being a shield 
for other kinds of stress, but also by acting as a maintainer of the architectural stability 
of the biofilm (Nobile et al, 2009). Matrix production is described in close link to 
biofilm formation (Nobile et al, 2009). It is known that the ECM abundance in C. 
albicans can be regulated positively or negatively by glucoamylases and alcohol 
dehydrogenases, for instance Gca1p, Gca2p and Adh5p which act as positive regulators, 
while Cshp and Ifd6p act as negative regulators (Nobile et al, 2009). In the study 
mentioned above, Al-Fattani and collaborators (Al-Fattani et al, 2006) showed that the 
synthesis of ECM material is dramatically increased during the biofilm development, 
which is subjected to a liquid flow and shaking, in opposition to minimal ECM 
synthesis under static incubation conditions. Despite this understanding, still very little 
is known about its regulation or production mechanisms (Nobile et al, 2009). 
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2. GUP1 
GUP1 gene was firstly described in S. cerevisiae encoding a multi-membrane-spanning 
protein essential for glycerol active uptake by proton symport (Holst et al, 2000). This 
was based on the fact that the deletion of GUP1 resulted (i) on a slow grow on glycerol 
as sole carbon and energy source, (ii) on a diminished ability to use extracellular 
glycerol for rescuing form osmotic stress and (iii) on a defect on active uptake of 
glycerol and metabolism (Holst et al, 2000). 
Soon after, Gup1p was included on the MBOAT (membrane-bound O-acetyl 
transferases) family (Hoffman, 2000; Neves et al, 2004), and involved in several 
processes connected with cell structure organization and biogenesis. It was described as 
having a role in the bipolar site selection, and several proteins sorting (Ny et al, 2001; 
bonangelino et al, 2002), cytoskeleton polarization (Ny et al, 2001), vacuole 
morphology (Bonangelino et al, 2002) telomere length maintenance (Askree et al, 2004) 
and plasma membrane composition evidenced by a reduction in phospholipids and an 
increase in triacylglycerols (Oelkers et al, 2000).  
This pleiotropism suggested the role of this protein in cellular processes to be of a 
complex nature. Further ahead, GUP1 was associated to cell wall morphology, 
synthesis and integrity (Ferreira et al, 2006). This is reinforced by the described GUP1 
genetic interactions with genes associated with chitin and β1,6-glucan synthesis, 
including SKT5 (activator of a chitin synthase involved in cytokinesis), RSV161 and 
RSV167 (both involved in actin polarizaton) (Ferreira et al, 2006). GUP1 gene interferes 
in lipid metabolism leading to deep alterations on sphingolipid-sterol ordered domains 
integrity/assembly as well as an abnormal sterol distribution at the level of plasma 
membrane (Ferreira et al, 2008).  
Ergosterol is an important constituent of membranes being target of common 
antifungals like azoles and polyenes (Pasrija et al, 2005). Several important roles have 
been attributed to sterol/sphingolipid-rich domains in dynamics processes such as 
protein sorting during exo- and endocytoses, cell polarity and signaling (Pasrija et al, 
2005). Ferreira and Lucas (Ferreira et al, 2008) showed Scgup1Δ mutant moderate 
sensitivity to sphingolipids biosynthesis inhibitors (SBIs), but a high resistance to 
ergosterol biosynthesis inhibitors (EBIs), including azoles. Following, Gup1p was 
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directly implicated in GPI anchors remodeling (Bosson et al, 2006). The authors 
showed that in ∆gup1 mutants the incorporation of ceramide in the anchors was 
disturbed, consequently the transport of the GPI protein Gas1p from endoplasmatic 
reticulum to Golgi was slower and part of it was lost into the medium (Bosson et al, 
2006). 
 All these observations clearly associating ScGup1p with lipids metabolism, with 
consequences on the resistance to antifungals (Ferreira et al, 2008), as well as with cell 
wall constitution, morphology and assembly (Ferreira et al, 2006), stress a putative 
importance for the biology of C. albicans, in particular, the switch from commensal to 
pathogenic nature and the subsequent increased resistance to antifungal drugs. 
 In the last years, our group started to study GUP1 gene in C. albicans. We have 
showed that GUP1 gene clearly has a role in C. albicans virulence (Ferreira et al, 2010). 
The deletion of GUP1 in C. albicans changes ergosterol plasma membrane 
constitution/distribution, presenting an increased resistance to azoles. More importantly, 
CaGup1p strongly interferes with the capacity of cells to develop hyphae, to adhere, to 
invade and to form biofilms, all of which considered significant virulence factors. 
Moreover, when treated with macrophages, the mutant Ca∆gup1 was much easily 
phagocytosed than wt strain and its survival was clearly impaired (Ferreira et al, 2010). 
 
2.1 GUP1 homologues 
Recently GUP1 gene attracted a great deal of attention because its mouse homologue 
was described as a negative regulator of the N-palmilotylation of Sonic hedgehog 
pathway from higher Eukaryotes (Abe et al, 2008), which controls morphogenesis, 
differentiation and patterning during embryogenesis, including proliferation and cell 
fate. This highly stresses the roles of Gup1 in cellular morphology and division control 
and comes into accordance with the results in yeast suggesting the existence of a 
putative Hh-like pathway in lower Eukaryotes. 
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Using the gene and protein databases available, it is possible to identify the existence of 
GUP genes and Gup proteins in many organisms, including Drosophila melanogaster, 
Mus musculus and Homo sapiens, which we chose to study. 
 
Fig.4. GUP1 homologues alignment based on sequence homology (NCBI Data Base Designation). 
 
Mammalian GUP1 is described on NCBI gene database as a homolog of S. cerevisiae 
GUP1 (Abe et al, 2008), and is consider to be a member of the membrane-bound O-
acyltransferase (Hoffman, 2000). MmGUP1 is also highly homologous to mammalian 
hedgehog acyltransferase, Skn, and importantly, the subcellular localization of 
MmGUP1 has been shown to be indistinguishable from the mouse Skn by green 
fluorescent protein analysis. As mentioned above it was identified as a negative 
regulator of Hh pathway (Abe et al, 2008). 
DmGUP1 is known as Rasp. The literature concerning this protein is practically 
inexistent. There is a study performed by Miccheli and co-authors, based on molecular 
alignment analysis, which describes Rasp as a multipass transmembrane protein that has 
homology to a family of membrane bound O-acyl transferases (Hoffman, 2000). They 
suggested that Rasp acylation is necessary to activate Hedgehog protein, an essential 
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component of Hedgehog pathway (Miccheli et al, 2002). An in silico analysis, revealed 
that the Rasp ORF (CG11495) used on the above mentioned work (Hoffman, 2000) 
presents a high homology with ScGUP1 gene (this study, Fig. 4). 
As for DmGUP1, there is very little information on Human GUP1. In fact, no studies 
with this gene have been made or published in the literature. Human GUP1 genomic 
sequence, available at NCBI database presents a high homology with MmGUP1 (this 
study, Fig. 4). 
 
2.2 HedgeHog pathway in mammalians 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Classical hedgehog pathway that leads to cells morphogenesis and proliferation 
(http://www.nature.com/nrd/journal/v5/n12/fig_tab/nrd2086_F1.html). 
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The glycoprotein Sonic Hedgehog (SHH) is essential for the development of several 
tissues during embryogenesis (Britto et al, 2000) and is also involved in organogenesis 
(Abe et al, 2008). SHH has additional functions in cell survival and cell proliferation 
(Ahlgren et al, 2002). Recent pieces of evidence suggest a major role for the activation 
of Sonic Hedgehog (SHH) signaling pathway in tumor development (Mao et al, 2009a; 
Mao et al, 2009b). Namely, SHH was involved in pathogenesis of neuroblastoma due to 
its high expression level in this pathology cells lines. Additionally, SHH inhibition 
induced apoptosis and stopped proliferation, abolishing the tumorgenecity of 
neuroblastoma (Mao et al, 2009a). 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Aims 
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Aims   
Gup1 is a yeast O-acyltransferase with close homologues in higher Eukaryotes 
(Hoffman, 2000; Neves et al, 2004) which has been implicated in the regulation of the 
Hedgehog pathway in mouse (Abe et al, 2008). 
In C. albicans the deletion of GUP1 causes drastic alterations both at morphologic and 
physiologic levels (Ferreira et al, 2010), such as (i) changes in the constitution and 
distribution of ergosterol in the plasma membrane, (ii) resistance to antifungals (azoles), 
(iii) aberrant colony morphology, (iv) impairment on the capacity of cells to develop 
hyphae, and (v) defects on the ability of cells to adhere, invade and form biofilms. 
Furthermore, when a copy of CaGUP1 gene is re-introduced to ∆gup1 mutant these 
phenotypes are reversed, indicating that the above phenotypes are directly connected to 
Gup1p function or its absence (Ferreira et al, 2010). 
Based on that, it was proposed as aim for the present work, to create and study several 
strains of C. albicans ∆gup1 mutant harboring available GUP1 homologues from well 
known model organisms/higher Eukaryotes: 
- Yeast - Saccharomyces cerevisiae (ScGUP1) 
- Fly - Drosophila melanogaster (DmGUP1) 
- Mouse - Mus musculus (MmGUP1) 
- Man - Homo sapiens (HsGUP1) 
These newly transformed C. albicans strains were tested for several virulence factors, 
such as: (i) morphology and differentiation; (ii) adherence and invasion capacities; and 
(iii) resistance to antifungals agents. 
Another important purpose of this study was to obtain a first characterization of the 
proteins secreted onto the C. albicans extracellular matrix, for which it was chosen to 
mimic biofilm formation on plate and compare the wt, ∆gup1 mutant and transformants 
for that matter.  
 
 
 
 
 
 
 
 
 
 
 
Material and Methods 
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1. Strains & growth conditions 
In this study C. albicans strains used were: wild type (wt) BWP17 
(ura3Δ::λimm434/ura3Δ::λimm434his1::hisG/his1::hisGarg4 ::hisG/arg4::hisG) 
(Wilson et al, 1999), several clones of homozygous C. albicans Δgup1/ Δgup1 (isogenic 
to BWP17 but gup1::URA3-dpl200/gup1::ARG4) named as Δgup1 mutant (Kayingo et 
al, 2009) and Δgup1 mutant complemented with GUP1 homologues from S. cerevisiae 
(ScGUP1), D. melanogaster (DmGUP1), Mus musculus (MmGUP1) and H. sapiens 
(HsGUP1), generally referred below as CaΔgup1GUP1 homologues.  
Yeast strains were batch-grown on rich medium (YPD - yeast extract (1% w/v), peptone 
(2% w/v), glucose (2%, w/v)), minimal medium (YNBD – yeast nitrogen base (0.67% 
w/v), glucose (2% w/v)) or Spider´s medium (Nutrient broth (1% w/v), manitol (1% 
w/v), K2HPO4 (0.2% w/v)), at 30ºC (YPD; YNBD) or 37ºC (YPD; Spider), with orbital 
shaking, at 200 rpm. Solid cultures media were supplemented with 2% agar (YPD, 
YNBD) or 1.5% agar (Spider) and identically incubated at 30 and 37°C. Transformants 
were grown at 30ºC on YNBD supplemented with 200 µg/mL geneticin (G418), until 
colonies were observed. Strains were kept at 4ºC on solid media. 
Escherichia coli XL1Blue strain (endA1 gyrA96 (nalR) thi-1 recA1 relA1 lac glnV44 
F'[::Tn10 proAB+ lacIq Δ(lacZ)M15] hsdR17(rK- mK+) was used for DNA 
propagation. Bacterial cells were grown in Luria-Bertani (LB) medium (yeast extract 
(0.5%, w/v); tryptone (1%, w/v); NaCl (1%, w/v)) at 37ºC in an orbital shaker. Strains 
were maintained in LB medium supplemented with 2% agar, previously grown 
overnight at 37ºC and kept at 4ºC. Bacterial transformants were grown overnight on LB 
medium with ampicilin (100 mg/ml) at 37ºC, until colonies were observed. 
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2. DNA manipulation 
A pair of plasmids, p413GPD and p423GPD, were used in this work to clone GUP1 
homologues (Fig. 7). Both are expression plasmids containing the strong GPD promoter 
and the selective marker histidine (Mumberg et al, 1995), but differ in replicative 
strength. p413 is centromeric and p423 harbours the 2µ element, which result in one 
copy per cell or in 10-30 copies per cell, respectively (Mumberg et al, 1995). The 
plasmid pRS42K was also used in this work (Taxis et al, 2006) (Fig. 7). This vector 
derives from pRS plasmid series and is an episomal shuttle plasmid used to easy genetic 
manipulation in yeast. It contains selective markers both to bacteria (ampicilin, 
kanamicin) and yeast (geneticin). 
 
 
 
 
 
 
 
Fig. 7. Schematic representation of p413GPD, p423GPD and pRS42K plasmids. 
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2.1 Transformation of C. albicans∆gup1 mutant strain 
The referred vectors, p413GPD, p423GPD and pRS42K were used to clone the several 
GUP1 homologues, ScGUP1, DmGUP1, MmGUP1 and HsGUP1 in C. albicans. These 
constructions were previously propagated in E. coli XL1Blue strain. 
2.1.1 Transformation in E. coli XL1Blue  
E. coli XL1Blue transformation was made following standard protocols and using 
prepared competent E. coli XL1Blue cells (Ausubel et al, 1996). The transformation 
selection was performed based on the autotrophic mark ampicillin present in both 
p4X3GPD and pRS42K plasmids. The procedure is next described: 
E. coli XL1Blue competent cells preparation was made using the Simple and Efficient 
Method (Inoue et al, 1990). The method basically consists on inducing membrane 
alterations that make cells more permeable to macromolecules, in the present case DNA 
on plasmids, which crosses the membrane more easily. 
To transform E. coli XL1Blue, a volume of 5 µl plasmid DNA (≈50 µg/µl) was added to 
200 µl of competent cells. These were maintained on ice for 40 minutes, subjected to a 
heat shock by incubation at 42ºC for 2 minutes and then incubated on ice for 2 minutes. 
In order to allow cells to recover, 500 µl of LB medium was added and the cell 
suspension further incubated at 37ºC for 1 hour. A volume of 100 µl of this suspension 
was then platted on solid LB medium supplemented with 100 µg/ml of ampicillin. Cells 
were allowed to grow overnight at 37ºC. 
 
2.1.2 Plasmid isolation from E. coli XL1Blue cells 
In order to isolate plasmidic DNA in large scale, several colonies of E. coli XL1Blue 
transformed with GUP1 homologues were inoculated in 5ml of LB-amp liquid medium 
and grown overnight at 37ºC. The plasmid extraction was performed with GeneElute
TM
 
Plasmid Miniprep Kit [Sigma], following the protocol of the manufacturer.  
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2.1.3 Enzymatic digestion of plasmidic DNA 
To extract the several GUP1 homologues from the different plasmids, appropriate pairs 
of restriction enzymes were used (Table 1). 
Table 1. Restriction enzymes used to extract GUP1 homologues. 
GUP1 origin Restriction enzymes 
ScGUP1 Hind III (1.5 µl); Xho I (0.75 µl) 
DmGUP1 Bam HI (1.5 µl); Xho I (0.75 µl) 
MmGUP1 Xba I (1.5 µl); Xho I (0.75 µl) 
HsGUP1 Spe I (0.5 µl) e Xho I (2 µl) 
 
The restriction enzymes Kpn I and Sac I were also used to clone these GUP1 genes into 
pRS42K, already harboring the GPD promoter and the terminator CYC1 (Danielly, 
master thesis, 2008). 
Plasmids linearization was obtained by the following reaction mixture: 
- 8 µl of vector, 
- X µl of enzyme A, 
- Y µl of enzyme B, 
- 2 µl of buffer, 
- Z µl ultrapure autoclaved water, 
As can be seen in Table 1, the volumes of the different enzyme combination are 
distinct. The ratio of volumes was calculated using the Fermentas double digestion tool 
(http://www.fermentas.com/en/tools/doubledigest). Ultrapure water was added to complete 
a final reaction volume of 20 µl. The mix was incubated for 2.5 to 3 hours at 37ºC.  
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2.1.4 Extraction of DNA fragments of agarose gel electrophoresis 
In order to separate, identify and purify DNA fragments, 1% agarose gel electrophoresis 
was performed. The DNA was visualized by UV illumination (245nm) at Eagle Eye II 
(Stratagene), previously stained with Gel RED (Biotium) dye. The molecular weight 
marker was Lambda DNA/Eco471 [Fermentas]. The electrophoresis ran for 
approximately 1 hour at 70 volts. The DNA fragments of interest were extracted with 
QIAquick Gel Extraction Kit (QUIAGEN) system following the manufacture 
recommendations. 
2.1.5 Ligation reaction 
Prior to ligation reaction the plasmid was treated with the enzyme Shrimp Alkaline 
Phosphatase (SAP) in order to remove phosphate 5’ ends of the vectors. This 
elimination prevents the auto-ligation of the vector and reduces the frequency of 
plasmid circularization during the ligation reaction (Sambrook et al, 1989). For that, the 
vector was incubated with SAP enzyme for 10 minutes at 37ºC. The mix was further 
incubated 15 minutes at 65ºC in order to a complete inactivation of the enzyme. 
The ligation reaction was performed using the following conditions: 
- 1 µl ligation buffer 10x, 
- 1 µl plasmid, 
- 7 µl of purified digestion product, 
- 1 µl of T4 DNA ligase, 
- 10 µl ultrapure water to achieve final volume of 20 µl, 
 
The reaction mixture was incubated overnight at 4ºC. For DNA propagation, the 
ligation product was used to transform E. coli XL1Blue competent cells, as described 
above. 
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2.1.6 Yeast transformation 
C. albicans ∆gup1 mutant strain was transformed following a protocol adapted from 
Gietz R.D. and collaborators, 1995 and Walther A. and collaborators, 2003. The 
procedure is next described: 
 Grow of ∆gup1 mutant strain in ≈5ml of YPD, overnight at 30ºC until 
stationary phase, 
 Ressuspend the cells on fresh YPD to OD600= 0.3, 
 Incubate for 4-5h at 30ºC, 
 Harvest the cells by centrifugation 5 min at 5000 rpm. Wash the pellet 
once with water. Carefully remove the remaining water, 
 Ressuspend the pellet in 1.5ml of LiAc/TE solution* (0.5 ml 10xTE; 0.5 
ml 10x LiAc; 4 ml water), 
 Set up transformation tubes as follows:  
. 1-5 µl DNA 
. 10 µl ssDNA (DNA carrier) 
. 80 µl cells 
. 600 µl PEG4000/LiAc solution* (2.5g PEG4000, 0.5 ml 
10x LiAc, 4.5 ml water) 
 Vortex briefly, and incubate overnight at 30ºC, 
 Heat shock for 15 minutes at 44ºC, 
 Spin down cells at 13000 rpm for 15 seconds and pour off PEG;  
 Spin down again and tip off remaining PEG, 
 Ressuspend the pellet in 100-200 µl water and plate the suspension on 
selective plates (YNB w/o aminoacids supplemented with geneticin (200 
µg/ml)); 
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 Incubate for 24-48h at 30ºC.; 
*Both solutions were sterilized by filtration. 
 
3. Virulence assays 
3.1 Morphology and hyphal formation 
In order to observe different colony morphology/differentiation, the cultures were 
diluted and inoculated in both liquid and solid medium, under hyphal non-inducing 
conditions (YPD at 30ºC) and under hyphal-inducing conditions (Spider medium, YPD 
at 37º and also YPD supplemented with 10% Fetal Bovine Serum (FBS) at 37º C). 
Solid media: Cultures were allowed to grow for 2-3 weeks. During this period the 
colonies were several times observed at light microscopy to inspect hyphal 
development.  
Liquid media: To discriminate between hyphae and pseudo-hyphae, young cultures 
were diluted to 1×10
7 
cells/ml (OD600=1), and incubated in the presence of FBS 10% 
(Fetal Bovine Serum) at 37ºC. At several time points a sample was collected and cells 
were stained with CFW (Calcofluor White) by adding to 3 ml of cell suspension 300 μl 
of CFW (300 μg/ml). Samples were incubated at room temperature for 5 min, after 
which 5 μl of the suspension was placed on microscopic slide, visualized by light 
microscopy (LM) and photographed. CFW dye binds primarily to chitin, but also in less 
extent to glucans, staining cell wall and septa of the cells (Ferreira et al, 2010). 
Microscopy assessments were done in a Leica Microsystems DM-5000B 
epifluorescence microscope, with appropriate filter settings. Images were acquired by a 
Leica DCF350FX digital camera and processed with LAS AF Leica Microsystems 
software. 
3.2 Adherence to agar and invasion capacities 
Equal volumes of young cultures of each strain were diluted to 1 × 10
7
 cells/ml 
(OD600=1), and 1 ml of cells suspension was spotted into YPD and Spider medium agar 
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plates. Cultures were allowed to grow at 37°C for 10 days. The cells on the surface were 
then removed by washing under running water (Guo et al, 2000; Hube et al, 2001) and 
visualized by LM. 
3.3 Resistance to antifungal drugs 
To attest Ca∆gup1GUP1 homologues sensibility/resistance to antifungal drugs, YPD-
grown cultures were used for drop tests, containing approximately 1×10
7
 cells/ml 
(OD600=1) as described before (Ferreira et al, 2008; Ferreira et al, 2010). Six-fold serial 
dilutions were made, and 5 μl of each suspension was applied on selective media. 
Results were scored after 3-5 days of incubation at 30°C. YPD medium was 
complemented as follow: clotrimazole (68.8 μg/ml), ketoconazole (86.1 μg/ml), 
fluconazole (30.6 μg/ml). All chemicals were obtained at the highest available grade 
from Sigma Aldrich (Ferreira et al, 2010). 
 
4. Proteins secreted to extracellular matrix (ECM) 
The extraction of proteins secreted to the extracellular matrix (ECM) was performed 
using an optimized protocol develop by our group (Joana Carvalho, unpublished 
results): 
In order to obtain a biofilm-like structure and ensure relevant quantities of secretome, 1 
ml of cells (OD600= 1) were spread on different mediums (YPD, Spider and YNB 
without aminoacids). The overlays were allowed to grow 7 days at 30°C and 37°C. The 
biomass of at least 5 plates (90mm) of each strain was scraped and immersed in PBS 
buffer containing a cocktail of proteases inhibitors (PMSF 0.2 µg/ml; Aprotinin 0.32 
µg/ml; Pepstatin 1µg/ml; Leupeptin 1µg/ml) in which cells were washed for 10 minutes 
on a roller under constant rotation, at 4°C. The suspension was then spun down for 5 
minutes at 5000 rpm. The supernatant was collected and stored at 4ºC for further protein 
analysis. 
To obtain a maximum protein recovery, proteins were precipitated overnight with a mix 
of TCA (Trichloroacetic acid) and DTT (Dithiothreitol) at 4°C. DTT has a protein 
protector effect that increases the yield of proteins recovery. A crucial step to perform 
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efficient protein extraction is the protein solubilization. Two alternative buffers were 
tested, urea and a modification of Laemmli buffer consisting on the withdraw of the 
bromophenol blue and the addition of urea (6M of final concentration), to previous 
Laemmli buffer (Joana C., unpublished results). This last one was chosen according to 
ressuspension efficiency determined by electrophoretic profile, as well as because it is 
compatible with the utilization of Bradford protein quantification method. To enhance 
the performance of the protein precipitation, two further steps of vortex and sonication 
were performed.  
SDS-PAGE was made in 9% of polyacrylamide in order to allow the use of a broad 
range of molecular weight marker. Electrophoretic run was performed during 1 hour at 
140 volts. The gel was stained with AgNO3. A formaldehyde fixation step, which 
enhances the staining sensitivity but precludes any further use of the stained bands, was 
introduced to the staining process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
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1.Strains harboring GUP1 homologues 
The cloning of several of the GUP1 homologues (ScGUP1; DmGUP1; MmGUP1 and 
HsGUP1) was initially performed into a pair of p4X3 series plasmids, with different 
expression strength (Mumberg et al, 1995). These plasmids have different origins of 
replication, a centromeric (p413) and a 2µ (p423) that vary in the number of copies 
produced (1 and 10-30 copies per cell respectively) (Mumberg et al, 1995). Yet, both 
have a strong promoter (GPD) and also share the same terminator (CYC1). 
In general, the strategy applied to clone the GUP1 homologues consisted in extracting 
the gene from the original plasmid (all GUP1 homologues were obtained already cloned 
in several plasmids) and cloned them into p4X3GPD plasmids. A restriction map was 
performed for the genomic DNA coding sequence of each GUP1 homologue in order to 
select the appropriate restriction enzymes to be used on the cloning steps, considering 
both the plasmidic Multi-Cloning-Site (MCS) and the restriction analysis. Each 
construction, p4X3GPD-GUP1 homologues, was then transformed in E. coli XL1Blue 
in order to obtain a larger stock of DNA. The E. coli XL1Blue transformants were 
selected in LB medium supplemented with 100 µg/ml of ampicilin. The positive clones, 
those who carry the GUP1 gene fragment, were verified through electrophoresis of the 
enzymatic digestion confirming the expected bands size. These positive clones were 
then frozen and stored at -80°C in glycerol stocks. 
To otain the ScGUP1-GFP chimera a previous pYES2-GUP1-GFP construction 
available at the collaborators Franscesco Grieco and Gianluca Bleeve (Istituto di 
Scienze Delle Produzioni Alimentari del Consiglio Nazionale Delle Ricerche (ISPA), 
Lecce, Italy) was used. The in silico restriction map was studied, covering the chimera 
GUP1-GFP and not only ScGUP1 gene (Fig. 8). Hind III and Xho I enzymes were 
chosen to extract the fragment form pYES2 and to clone it in p4X3GPD, once these 
were included simultaneously into the MCS (Multiple Cloning Site) of both plasmids 
and do not cut the chimera ScGUP1-GFP (Fig. 8).  
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Fig.8. Restriction map of GUP1-GFP chimera, obtained with Nebcutter V2.0 program [New England 
Biolabs Inc.]. 
The XL1Blue clones were digested with Hind III and Xho I enzymes and the resulting 
product analyzed by electrophoresis (Fig. 9). The positive clones were confirmed by the 
presence of the two expected bands: a band of approximately 6000 bp corresponding to 
the empty plasmid (5876 bp) and of a band of approximately 2500 bp corresponding to 
the chimera ScGUP1+GFP (1683 bp of GUP1 plus 717 bp of GFP). 
 
 
 
 
 
 
 
 
Fig. 9. Electrophoretic analysis of clones containing p4X3GPD-ScGUP1-GFP construction. Molecular 
weight marker Lambda DNA/Eco471, Marker 13 [Fermentas] – lanes 1 and 12; Product of the double 
digestion with Hind III and Xho I of the clones harboring p413GPD-ScGUP1-GFP - lanes 2 to 11. 
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DmGUP1 was obtained from the same source as ScGUP1-GFP and cloned into 
p426GPD plasmid. After the restriction analysis, Bam HI and Xho I enzymes were 
chosen to extract DmGUP1 from p426GPD and clone into p4X3GPD plasmids (Fig. 
10). 
 
 
 
 
 
 
 
 
Fig. 10. Restriction map of DmGUP1 gene, obtain with NEBcutter V2.0 program [New England Biolabs 
Inc.]. 
 
Again to verify the presence of DmGUP1 gene on the XL1Blue transformants, the 
plasmidic DNA was extracted and double digested with Bam HI and Xho I enzymes. 
The gel electrophoresis of the double digestion confirmed the presence of DmGUP1 
gene with approximately 1600bp (Fig. 11 -lanes 2 and 3- green arrow). Empty 
p413GPD plasmid (lane 2 – blues arrow) and p423GPD plasmid (lane 3 – black arrow) 
have approximately 5900 bp and 6700 bp, respectively. 
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Fig. 11. Electroforetic analysis of double digestion of p4X3-DmGUP1. Molecular marker Lambda 
DNA/Eco471 Marker, 13 [Fermentas] - lanes 1 and 4; Double digestion with Bam HI and Xho I of 
p4X3GPD -DmGUP1 clones - lanes 2 and 3. 
 
MmGUP1 gene was gently provided by Abe et al (Abe et al, 2008) into a p426GPD 
plasmid. As before, a restriction analysis was made and Xho I and Xba I enzymes 
chosen for the extraction of the fragment and the cloning into p413GPD and p423GPD 
plasmids (Fig. 12).  
 
Fig. 12. Restriction map of MmGUP1 gene, obtain with NEBcutter V2.0 program [New England Biolabs 
Inc.]. 
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Three XL1Blue transformants were double digested with the same enzymes and 
analyzed by electrophoresis (Fig. 13). Two clones displayed two bands, one of 
MmGUP1 gene (≈1500bp) and the other corresponding to the empty p413GPD 
(≈5900bp) (Fig. 13. lanes 3 and 4). On the other hand, in the clone of lane 2 only the 
presence of empty plasmid was visualized, meaning that the MmGUP1 gene was not 
incorporated into this clone. Therefore, only clones 3 and 4 were considered positive. 
 
 
 
 
 
 
 
Fig. 13. Electrophoretic analysis of the double digestion of p413-MmGUP1. Molecular Marker - lane 1; 
Double digestion with  Xba I and Xho I of p413-MmGUP1 clones-  lanes 2, 3 and 4;  
A turning point on this work arose when we tried to clone ∆gup1 mutant strain with the 
p4X3GPD constructions harboring the GUP1 homologues (from ScGUP1; DmGUP1; 
MmGUP1). Despite of the several attempts and protocols used, CaΔgup1GUP1 
homologues clones were never achieved. We hypothesized that this difficulty could be 
related with the aminoacid selection of the p4X3GPD plasmids. Apparently the marker 
gene, histidine, was not stringent enough as selection force, preventing us to obtain 
positive clones. These complications have been described by other researchers 
(Danielly, master thesis, 20008; Pacheco, PhD thesis, 2008).   
We decided to clone all GUP1 homologues into a new plasmid, the pRS42K, an 
integrative epissomal plasmid, whose selective force arises as more reliable since is an 
antibiotic (Taxis et al, 2006). However, this vector is not an expression plasmid, since it 
lacks the promoter and terminator (Taxis et al, 2006). The strategy thus to extract from 
the p4X3GPD plasmids constructions previously build, the fragment containing the 
GPD promoter, the GUP1 homologues and the CYC1 terminator and insert the whole 
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fragment into pRS42K plasmid, thereby arming pRS42K of a promoter and terminator 
(Fig. 14). The restriction enzymes Kpn I and Sac I were used to extract the fragments 
containing ScGUP1 and DmGUP1 homologues from p413 plasmids and to clone into 
pRS42K.  
 
Fig. 14. Schematic representation of the cloning strategy used to insert the fragment GPD-
GUP1homologues- CYC1 into pRS42K plasmid. 
The constructions obtained were transformed into E. coli XL1 Blue strain for DNA 
propagation. The confirmation of positive clones was achieved as before, by extracting 
the plasmid from E. coli XL1 Blue clones and subjecting these to enzyme digestion 
according to each GUP1 homologue and subsequent gel electrophoresis analysis:  
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The pRS42K-ScGUP1 clones were digested with Kpn I (Fig. 15). The resulting 
linearized plasmid of a positive clone should give a band with 9373 bp corresponding to 
pRS42K-GPD-ScGUP1-GFP-CYC1 full size (6006bp of pRS42K plus 3367 of the 
fragment GPD-ScGUP1-GFP-CYC1) (Fig. 15- lanes 2 and 4). 
 
 
 
 
 
 
 
 
 
Fig. 15. Electroforetic analysis of pRS42K-GPD-ScGUP1-GFP-CYC1 digested with Kpn I. Molecular 
weight marker - Lane 1; pRS42K–GPD–ScGUP1-GFP-CYC1 clones - lanes 2, 3 and 4;  
 
The pRS42K DmGUP1 clones were double digested with Kpn I and Sac I (Fig. 16). We 
expected two bands for the digestion product of positive clones: one corresponding to 
the empty pRS42K (≈6006 bp) and another corresponding to the fragment GPD-
DmGUP1-CYC1 (~2500 bp) (Fig.16 – lanes 2, 4 and 5). 
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Fig. 16. Electrophoretic analysis of ligation product pRS42K-GPD-DmGUP1-CYC1 digested with Kpn I 
and Sac I. Molecular weight marker - Lane 1 and 6; pRS42K-GPD-DmGUP1-CYC1 clones - Lanes 2, 3, 
4, and 5. 
 
Concerning the HsGUP1 homologue a different strategy was taken to clone it into 
pRS42K. This gene was available in our lab cloned into p426GPD plasmid (Fábio 
Faria-Oliveira, unpublished results), originating from a cDNA form ORFeome 
Collection from Dana Farber Cancer Institute, Boston, USA). p426GPD plasmid 
belongs to the same series of plasmids of p4X3 (Mumberg et al, 1995) and therefore has 
similar MCS. The restriction enzymes, Kpn I and Sac I, used before, have restriction 
sites inside the HsGUP1 sequence and therefore couldn’t be used. Instead we used 
another pRS42K plasmid construction, containing already this promoter and this 
terminator pRS42K-GPD-DhXYLH-CYC1 (Danielly, master thesis, 2008). DhXYLH is 
the genomic sequence from the yeast Debaryomices Hansenii xylose symporter 
(Danielly, master thesis, 2008). The sequence was removed from pRS42K, using Spe I 
and Xho I restriction enzymes. The same enzymes were used to extract HsGUP1 gene 
from p426GPD plasmid and to clone it into the pRS42K (Fig. 17). 
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Fig. 17. Schematic representation of the cloning strategy used to insert HsGUP1 and MmGUP1 into 
pRS42K plasmid containing a promoter and a terminator. 
 
The construction was used to transform E. coli XL1Blue strain. The clones pRS42K 
HsGUP1 were digested again with the same enzymes to confirm HsGUP insertion (Fig. 
18). The two expected bands were obtained: one of approximately 6000bp 
corresponding to linearized pRS42K containing the promoter and the terminator, and 
another band of 1500bp, corresponding to the size of HsGUP1 gene. Two positive 
clones were obtained following with this approach (Fig. 18. lanes 2 and 3). 
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Fig. 18. Electroforetic analysis of pRS42K-GPD-HsGUP1-CYC1 digested with Spe I and Xho I. 
Molecular weight marker - lane 1; pRS42K-GPD-HsGUP1-CYC1 clones - lanes 2 and 3; 
 
To clone MmGUP1 we used the same approach as for HsGUP1, meaning that the 
fragment MmGUP1 was removed from p426GPD plasmids (Fabio Faria-Oliveira- 
unpublished results) with Spe I and Xho I enzymes and cloned into empty pRS42K 
plasmid containing GPD promotor and CYC1 terminator obtained before (Fig. 17). The 
construction was used to transform E. coli XL1Blue strain and the insertion of 
MmGUP1 gene was verified as before. Despite of several attempts, none of the clones 
obtained with this construction harbored the MmGUP1 gene. 
 
2. Virulence assays with the C. albicans complemented 
strains 
C. albicans ∆gup1 mutant strain was transformed with the pRS42K constructions 
harboring GUP1 homologues (from ScGUP1, DmGUP1 and HsGUP1) as described in 
Material and Methods section 2.1.6. Yeast transformants were selected through its 
resistance to geneticin and tested for virulence related phenotypes.  
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2.1 Colony morphology and hyphal formation capacity 
The colony morphology and capacity of cells to develop hyphae of the several 
Ca∆gup1GUP1homologues were tested in both solid and liquid media. 
Solid media: wt, ∆gup1 mutant and Ca∆gup1GUP1 homologues strains were grown for 
2 weeks on YPD agar plates, at 30°C (non-hyphae-inducing conditions) and on YPD 
and Spider medium at 37°C (hyphae-inducing conditions), before colony morphology 
inspection. As described before, ∆gup1 mutant exhibit different colony morphology 
when compare with wt (Ferreira et al, 2010). On the other hand, the colonies of 
Ca∆gup1GUP1 homologues strains didn’t display the spaghetti/flower kind 
morphology characteristic of ∆gup1 mutant  and in that sense, were closer to the wt 
colony morphology (Ferreira et al, 2010). Yet, neither of the Ca∆gup1GUP1 
homologues presents hyphae differentiation and wt strain has that capacity (Ferreira et 
al, 2010). Thus, in solid media the GUP1 homologues were not able to revert ∆gup1 
mutant defect to develop hyphae, although all affected colony morphology (not shown). 
Liquid media: Time-course of hyphae formation induced by FBS (fetal bovine serum) 
in liquid medium was checked. Calcofluorwhite (CFW) binds mainly to chitin (Herth et 
al, 1980), one of the cell wall compounds, allowing us to see the cell wall, the budding 
scars and the septas (Hoch et al, 2005). Contrarily to ∆gup1 mutant, the 
Ca∆gup1GUP1homologues harboring the different homologues ScGUP1, DmGUP1 
and HsGUP1 were able to differentiate into pseudo-hyphae/hyphae cells, very soon 
after induction (5 min.) as shown in Fig. 19. This, however, stabilizes/stops after 30 
minutes of incubation with FBS (Fig. 19). Our statement is based on the the observation 
that after the refered period is not possible to see alterations on the size of 
hyphae/pseudo-hyphae cells. Furthermore, the stained wall indicate that the filamentous 
cells developed by these strains are more likely to correspond to pseudo-hyphae rather 
than true hyphae, since i) first septum is close to the mother neck, ii) present 
constrictions at the septa junctions and iii) the side walls are not parallel (Fig. 19 - white 
arrows). This is in clear contrast to wt cells, which form true hyphae, once the first 
septum of these filamentous cells is distant from the mother neck and the other septa do 
not present constrictions (Fig. 19 - red arrows). It is further noteworthy that 
Ca∆gup1GUP1homologues cells were significantly smaller than wt.  
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Fig. 19. Time-course pseudo-hyphae/hyphae formation in wt, ∆gup1 mutant and 
Ca∆gup1GUP1homologues, in liquid hyphae inducing medium (FBS). Cells were stained with CFW and 
observed by LM with the adquated filters.  
 
2.2 Adherence to agar and invasion capacities  
In order to evaluate the Ca∆gup1GUP1homologues strains capacity to adhere and to 
invade agar, cells were grown for ten days on both YPD and Spider agar plates. Ended 
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this period the plates were washed under running water. In a previous publication it was 
described how the deletion of GUP1 interferes in the capacity of the strain to both 
adhere and invade these surfaces (Ferreira et al, 2010). All the transformants revealed 
the same lack of adherence capacity/level to YPD and Spider plates, since they were 
washed out as easy as ∆gup1 mutant from the agar surface. 
Replicas of these plates were further inspected for agar invasion as described in 
Materials and Methods- section 3.2. In a previous work we showed that ∆gup1 
mutant,was deficient on the ability to invade these surfaces (Ferreira et al, 2010). Here, 
we observed that the complementation of the ∆gup1 mutant with the mentioned 
homologues did not reverted this phenotype (not shown). In fact, none of the 
Ca∆gup1GUP1homologue strains were able to invaded the agar, at all the conditions 
tested. 
 
2.3 Resistance to antifungals 
The O-acyltransferase Gup1p acts on lipids metabolism affecting the assembly and 
integrity of the plasma membrane, as well as the sphingolipids-sterol order domains 
(Ferreira et al, 2008). An association between altered lipid-ordered domains and 
antifungal resistance has been described before as influencing the susceptibility to 
antifungal drugs (Mukhopadhyay et al, 2004; Ferreira et al, 2008). Regarding 
Ca∆gup1GUP1homologues strains, the two harboring the ScGUP1 and the HsGUP1 
genes seem to be more resistant to these antifungals than the wt strain, showing a 
similar behavior to ∆gup1 mutant strain (Fig. 20, 3th and 5th columns). However the 
strain complemented with DmGUP1 gene was as sensitive to these drugs as wt strain 
(Fig. 20. 4
th
 colunm), differing from the other complemented strains.  
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Fig. 20.  C. albicans wt, ∆gup1 mutant and Ca∆gup1GUP1homologues strains sensitivity to different 
antifungals. All strains were treated as described in Material and Methods section 1.3.3. 
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3. Extracellular matrix profiles 
The C. albicans ability to invade tissues and form biofilms is related to the formation of 
an ECM yet uncharacterized in detail (Douglas, 2003). Similarly to what happens in 
higher Eukaryotes, it is likely that the constituents of the matrix influence and relation 
to the morphological switch or, more broadly, control the multicellular aggregates 
morphology. Moreover, the GUP1 gene from mammals was implicated in the regulation 
of the morphogenic Hedgehog pathway (Abe et al, 2008). This prompted us to attempt a 
first approach to the C. albicans ECM using the present constructions. The analysis of 
ECM proteins from C. albicans was performed using a novel methodology developed to 
efficiently extract the yeast ECM (Joana Carvalho, unpublished results). 
We started to compare the ECM proteins of wt and ∆gup1 mutant strains grown on ideal 
conditions (YPD at 30°C). For that, 5 plates (with 1 ml of culture per plate) of each 
strain were grown during 5 days, in order to obtain a mature biofilm-like structure. This 
was collected, the protein and sugar fractions separated and the proteins precipitated as 
described in Materials and Methods- section 4. The SDS revealed that different buffers 
ressuspend different proteins, as is mirroned by the different protein profiles (Fig. 21- 
green arrows) and modified Laemmli appears as the best ressuspension buffer since the 
bands are better defined and the protein pattern is more easily visualized (Fig. 21- lane 3 
and 6). Furthermore, regarding the comparison of the protein profile of ∆gup1 mutant 
strain with wt strain, the differences in the protein pattern are notorious, independently 
of the ressuspension buffer used. This suggests that ∆gup1 mutant excrete different 
proteins to the extracellular matrix of those excreted by wt, but also excrete proteins in 
distinct quantities than wt (Fig. 21. red circles). This is not unexpected since it was also 
observed in S. cerevisiae liquid cultures (Ferreira et al, 2006). 
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Fig. 21. SDS gel of the ECM proteins of wt and ∆gup1 mutant grown on YPD 30º C. 
 
Next we analyzed the ECM protein profiles of the same strains grown in different 
conditions: YPD at 37°C, Spider medium at 37°C and YNB without aminoacids at 
30°C. These conditions were chosen to observe possible differences in the protein 
profiles when the strains are submitted to hyphae induction conditions (YPD at 37°C 
and Spider medium at 37°C) and to minimal conditions (YNB without aminoacids at 
30°C). 
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Fig. 22. SDS gel of the ECM proteins wt and ∆gup1 mutant grown on  YPD at 30º C (column A); at 37º 
C (column B) and on Spider medium at 37º C (column C); All proteins were ressuspended in modified 
Laemmli buffer. 
 
The ECM protein profile of ∆gup1 mutant was again very distinct from the one 
displayed by wt (Fig. 22. red arrows). However, probably the most significant result 
was that under induction hyphae conditions the protein profiles displayed a considerable 
reduced quantity of proteins, independently of the strain used (Fig. 22. columns B and 
C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
    47 
 
  
I 
S. cerevisiae Gup1p is an acyltransferase involved in lipids metabolism/rafts stability 
and on the resistance to antifungals (Ferreira et al, 2008), as well as in the cell wall 
constitution, morphology and assembly (Ferreira et al, 2006). These are important 
features to be considered when regarding both C. albicans switch from commensal to 
pathogen and its increased resistance to antifungal drugs. Moreover, in 2008, Abe and 
collaborators (Abe et al, 2008) described that mammalian GUP1 as a negative regulator 
of N-terminal palmitoylation of Sonic hedgehog of Hedgehog pathway, which among 
other functions is involved in morphogenesis in mammalian cells (Abe et al, 2008). In a 
previous work, our group has shown that C. albicans virulence and drug-resistance 
requires Gup1p (Ferreira et al, 2010). Our assumptions were based on the following 
observations. First, gup1 mutant strain was resistant to common antifungals. Second, 
CaGUP1 deletion incited an aberrant evenly ergosterol distribution at the level of 
plasma membrane. Third, the ability to switch from yeast-form to hyphae-growth 
required CaGUP1. Fourth, a distinct growth orientation elicited by the deletion of 
CaGUP1 leaded to colonies with remarkable distinct/aberrant morphology i.e. a flower, 
spaghetti, irregular and wrinkled shape. Fifth, gup1 mutant strain adherence and 
invasion abilities were strongly reduced. Sixth, biofilm formation, another important 
indicator of C. albicans virulence, was strongly impaired by the deletion of CaGUP1. 
Finally, the introduction of the GUP1 gene copy into the gup1 mutant strain was able 
to revert all these phenotypes, symptomatic of the GUP1 gene accountability.  
All taken, and considering the fact that MmGUP1 gene was able to complemented the 
hypha morphogenetic defects on solid media of gup1 null mutant (Ferreira et al, 
2010), we anticipated that Gup1p might be part of a yeast morphogenic pathway, 
parallel to the mammalian Hedgehog. Several approaches are being developed by our 
group to unveil and characterize this pathway, both in S. cerevisiae and C. albicans. The 
present thesis focused on C. albicans approach. For that, we clone several GUP1 
homologues from lower to higher eukaryotes (S. cerevisiae, D. melanogaster and H. 
sapiens) and evaluated the level of complementation of each homologue concerning 
some of the virulence factors affected by GUP1 deletion, namely hyphae development, 
adherence and agar invasion but also regarding antifungals resistance.  
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II 
The initial approach to clone GUP1 homologues was performed using p4X3GPD 
plasmids series (Mumberg et al, 1995). p413GPD and p423GPD are considered useful 
tools for cloning procedures in yeast. The only distinction between them is the different 
expression strength, p423GPD ensures high expression, while p413GD only produces a 
copy of the recombinant protein per cell (Mumberg et al, 1995). Although the 
constructions p4X3GDP-GUP1 homologues were efficiently cloned in E. coli, when 
transformed into C. albicans no clones were achieved regardless of the genomic 
sequence cloned. We were not able to obtain colonies from these transformations. 
Instead an undifferentiated amount of biomass (background) was attained on the 
selective media. This suggests the lost of the insertion and therefore, a high level of 
instability of these constructions. Although heterologous expression of plasma 
membrane proteins are traditionally considered very tricky, and consequently the 
structural instability of the expression vector may result into the lost or rearrangement 
of the plasmid, we first considered that the main reason could be associated with a weak 
(not stringent enough) selective force of the aminoacid marker, histidine. This problem 
has been described before by other groups (Danielly, master thesis, 2008; Pacheco, PhD 
thesis, 2008). For instance, a plasmid from the same series of p4X3GPD, the p416GPD, 
was utilized to express the gene HSP12 in S. cerevisiae revealing genetic instability. 
The same happened on the heterologous expression of LGT1 in Torulaspora delbrueckii 
(Pacheco, PhD thesis, 2008) and on the heterologous expression of D. hansennii xilose 
symporter DhXYLH in S. cerevisiae (Danielly, master thesis, 2008).  
GUP1 homologues were then cloned into a cloning vector, pRS42K, along with the 
GPD promoter and CYC1 terminator. This plasmid has a strong selection marker, the 
antibiotic geneticin (G418). Furthermore, it has been described to enhance the flexibility 
of genetic manipulations and gene expression in yeast (Taxis et al, 2006), increasing the 
possibilities of the gene be expressed in larger quantities (Futcher et al, 1983). Using 
this plasmid the cloning of ScGUP1, DmGUP1 and HsGUP1 in C. albicans ∆gup1 
mutant strain was successful. 
 
III 
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The ability to switch rapidly between yeast-to-hyphae forms of growth is a defining 
characteristic of C. albicans cells. Nevertheless, each form of growth provides critical 
functions required for pathogenicity/virulence. Namely, hyphae form is thought to 
facilitate host tissues invasion and escape from phagocytic destruction (Whiteway et al, 
2007; Sudbery et al, 2004; Slutsky et al, 1985). According to previous works, ∆gup1 
mutant is not able to develop hyphae or pseudo-hyphae in solid media, and presents a 
great delay in doing so in liquid media (Ferreira et al, 2010). Moreover, ∆gup1 mutant 
displays distinct colony morphology (spaghetti/flower shape) (Ferreira et al, 2010). The 
insertion of GUP1 homologues into ∆gup1 mutant reverted this morphology pattern, 
turning colonies smooth and round. Yet, this reversion was not complete, since 
Ca∆gup1 transformants were not able to develop the hyphae or pseudo-hyphae 
characteristic of wt strain in any tested media (YPD and Spider at 37ºC) (not shown). 
This suggests the possible existence of some steps during the process of differentiation 
and that these homologues are only able to complement some of those stages, leading to 
an intermediated morphology between the sphagetti-like form of ∆gup1 mutant and the 
filamentous one of wt. On the other hand, macroscopic morphology may not entirely 
depend on cellular differentiation/hyphae formation, and be under the control of other 
signaling via, which GUP1 homologues were not able to complement.  
In agreement, Ca∆gup1GUP1homologues transformant strains when submitted to 
filament development induction with FBS in liquid cultures were only capable of 
differentiate into hyphae and pseudo-hyphae during the first moments of induction. In 
fact, these strains form filamentous cells as soon as induction is applied (at a minutes 
scale), whereas ∆gup1 mutant has a big delay to start developing hyphae and pseudo-
hyphae (Ferreira et al, 2010). After 30 min of incubation with FBS, all the transformants 
stop the hyphae elongation/growth, being for that reason all the hyphae cells composed 
only by two or at most three cells. This is quite interesting since, although ∆gup1 
mutant requires 2.5 h more to start the filamentous development than wt, after 4 or 5 h, 
the length of ∆gup1 mutant filamentous cells are quite similar to wt ones (Ferreira et al, 
2010). On the other hand, C. albicans invasiveness requires that cells differentiate into 
hyphae and/or pseudo-hyphae (Sudbery et al, 2004). Accordingly, none of the 
transformant strains were able to invade the agar. It seems that the signaling for starting 
filamentous development is complemented by ScGUP1, DmGUP1 and HsGup1 genes, 
but the following steps are not. Discover the events that are behind this interruption 
constitute a stimulating/interesting future project.  
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Other crucial features on C. albicans pathogenicity are the adherence and biofilm 
formation abilities. In this work we did not evaluate the biofilm formation aptitude of 
the transformant strains, yet we did assess the adhesion of those strains to YPD and 
Spider medium. ∆gup1 mutant has a reduced potential to adhere the agar, which is 
mirrored by the easiness with which this strain is washed out from the agar (Ferreira et 
al, 2010). The introduction of the GUP1 homologues into gup1 mutant did not cause 
any amend to its adherence ability, which lead us to extrapolate that possibly also the 
biofilm formation skill will most probably be defective on those strains.  
 
IV 
Modifications on the membrane lipid composition (phospholipids and ergosterol), on its 
fluidity and asymmetry can be important determinants of yeast cells susceptibility to 
antifungal drugs (Pasrija et al, 2005). Both S. cerevisiae and C. albicans ∆gup1 mutants 
present an altered sterol distribution across the plasma membrane, accompanied by an 
increased resistance to antifungal agents such fluconazole, ketoconazole and 
clotrimazole (Ferreira et al, 2008; Ferreira et al, 2010). These antifungals belong to the 
class of the azoles and are commonly used to treat Candida infections. The pathways 
involved in C. albicans lipid bionsynthesis are not well documented, yet in S. cerevisiae 
it is known that these drugs operate on the biosynthesis of ergosterol at the C-14 
demmethylation stage (Song et al, 2007), causing a depletion on ergosterol and 
accumulation of lanosterol. In our study the Ca∆gup1GUP1 homologues with ScGUP1 
and HsGUP1 had a growth behavior very similar to ∆gup1 mutant, meaning that these 
strains were as resistant to EBIs as the mutant. This suggests that the resistance to 
antifungals phenotype of ∆gup1 mutant was not complemented by ScGUP1 and 
HsGUP1 homologues. On the other hand, DmGUP1 gene seems to revert ∆gup1 mutant 
phenotype, showing a similar susceptibility to EBIs as wt strain. The observation of 
filipin stained sterols at the plasma membrane of these transformant strains would be of 
great interest. We would expect an even sterol distribution characteristic of Δgup1 
mutant for the strains harboring ScGUP1 and HsGUP1 and a normal punctuated plasma 
membrane sterol distribution for the strain carrying DmGUP1 gene.  
V 
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The characterization C. albicans ECM proteins is of enormous significance concerning 
the discovery and identification of the main players of cell-cell communication (Joana 
Carvalho, unpublished results). While some few studies were published, namely on C. 
albicans ECM that connects the cells within the biofilm structures (Ramage et al, 2005; 
Mukherjee et al, 2004;  Martins et al, 2010; Sutherland, 2001; Al-Fattani et al, 2006), 
and on wild S. cerevesiae strains colonies (Stovicek et al, 2010; Váchová et al, 2011), 
this subject has been largely neglected. Thomas and co-workers (Thomas et al, 2006) 
paper was one of the very few that addressed the identification of C. albicans ECM 
proteins in relation with virulence. These authors performed the proteomic comparative 
analysis of cell surface-associated proteins and secreted components (among other 
subcellular fractions) of both liquid and biofilm C. albicans cultures. They found some 
differences that could be associated with the role of biofilm on the Candida infections.  
Bearing in mind the fact that the GUP1 homologues from higher Eukaryotes interfere in 
the morfogenic Hedgehog pathway that controls and is controlled through the ECM 
components, and in view of all the results above, we considered pertinent to explore the 
protein composition of the C. albicans ∆gup1 mutant and the above-mentioned 
transformants, eager to find differences on the yeast ECM protein profiles. In fact, the 
ECM protein profile of ∆gup1 mutant was clearly distinct in all conditions tested. The 
∆gup1 mutant SDS-PAGE profile not only showed proteins that were not apparent on 
the wt profile, but also some of the common proteins were present at different 
concentrations. Interestingly, when either strain was cultivated at high temperatures 
(37C), the ECM proteins profiles exhibited considerably less proteins.  
If we bear in mind the phenotypes of ∆gup1 mutant in S. cerevisiae, a possible 
rationalization for such events could be the instability that the absence of Gup1p causes 
on the cell wall and membrane composition, assembly, and stability (Ferreira et al, 
2006; Ferreira et al, 2008) but also on the protein endocytosis and exocytosis processes 
(Bosson et al, 2006; Bonangelino et al, 2002). However, one can speculate that some of 
the proteins excreted by ∆gup1 mutant present on our profiles may be associated to the 
adherence, biofilm formation and hyphae development deficiencies of this strain, as 
well as with its increased resistance to the antifungal drugs. The future identification 
and characterization of the interesting proteins present on those profiles will definitely 
provide important information in this regard.  
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Final comments 
Considering all the results obtained in this work, we may conclude that ScGUP1, 
DmGUP1 and HsGUP1 only partially complement Ca∆gup1 mutant defects. In what 
concerns antifungal resistance, only DmGUP1 which is actually more similar to Gup2 
(unpublished results from Fábio faria-Oliveira), was able to revert ∆gup1 mutant 
phenotype, showing a similar susceptibility to EBIs as wt strain. Regarding hyphae 
differentiation on liquid media, all the GUP1 homologues were able to start developing 
filamentous cells, but unable to give continuity to that differentiation. In agreement, on 
solid cultures, although displaying a colony morphology closer to wt strain, the 
transformants were unable to differentiate into hyphae, exception made of MmGUP1 
that complemented hyphae differentiation defect of ∆gup1 mutant in solid media 
(Ferreira et al, 2010). This strain was nevertheless not further tested. It is well known 
that heterologous expression of proteins despite of the system used, E. coli, yeast or 
even mammalian or plant cells, results in lower expression levels than on the original 
cells (Grisshammer et al, 1995; Sarramegna et al, 2003). This is even more critical if the 
protein is a plasma membrane resident (Hamacher et al, 2002; Vilalba et al, 1992), as is 
the case of Gup1p. Further studies are required to conclude about GUP1 homologues 
complementation efficiency of ∆gup1 mutant phenotypes in relation to expressed 
protein amounts, and consequently infer on their common functions. 
 
 
 
 
 
 
 
 
 
 
 
Future work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    54 
 
  
Future work 
Our results, although preliminary open a field of options for future research, mainly 
regarding proteomics of ECM and its relation to the virulence of C. albicans. To 
consolidate our observations, namely concerning the hyphae/pseudo-hyphae 
development and the resistance to antifungals agents of these GUP1 homologues, 
further assays are needed: 
1. Test new clones of these transformants to attest if the results obtained were due 
to different expression levels of the proteins.  
2. Test the strains with the empty plasmid to confirm that the events are in fact 
owed only to GUP1 homologues insertion.  
3. Clone MmGUP1 in the same plasmid (pRS42k) and test it regarding: (i) 
adherence and agar invasion; (ii) hyphal formation ability in liquid cultures; and 
(iii) resistance to antifungals; 
4.  Complete the virulence assays namely study the ergosterol distribution and the 
biofilm formation ability of these transformant strains. 
5. Analyze the protein profile of wt, ∆gup1 mutant as well as of the transformant 
strains in 2D-electrophoresis to further identification of key proteins present in 
the strains.  
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